Physician profile
Michael Robert Centilli
NPI 1215223326
$10,479.23
in general payments reported to CMS, 2019-2025
38 companies · $1,907 in 2025
The $1,907 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $556 · 2021: $673 · 2022: $1,841 · 2023: $2,171 · 2024: $2,384 · 2025: $1,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,138 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,138.08 |
| Education | $323.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,157.02 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Sun Pharmaceutical Industries INC. | $1,030.17 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Pfizer INC. | $760.69 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $748.17 | 2019-2025 | Libtayo, Dupixent |
| Janssen Biotech, INC. | $545.55 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Leo Pharma INC. | $479.42 | 2019-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $474.79 | 2019-2025 | |
| Galderma Laboratories, L.P. | $459.43 | 2019-2025 | Nemluvio, Aklief |
| Almirall LLC | $455.08 | 2021-2025 | Klisyri |
| Genzyme Corporation | $417.64 | 2021-2025 | |
| Amgen INC. | $413.68 | 2021-2024 | Otezla, Enbrel |
| Hill Dermaceuticals, INC. | $412.73 | 2024 | Tolak |
| Lilly USA, LLC | $362.27 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $331.56 | 2019-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $327.57 | 2021-2025 | Opzelura |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $271.32 | 2019-2025 | Jublia, Cabtreo, Arazlo |
| E.R. Squibb & Sons, L.L.C. | $222.22 | 2022-2025 | Sotyktu |
| Sensus Healthcare, INC. | $220.28 | 2020-2021 | |
| Dermavant Sciences, INC. | $213.23 | 2023-2024 | Vtama |
| Organogenesis INC. | $188.38 | 2023-2025 | Puraply, Novachor |
| Arcutis Biotherapeutics, INC. | $185.06 | 2023-2024 | Zoryve |
| Kerecis Limited | $145.27 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Biofrontera INC. | $142.66 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Mayne Pharma Commercial LLC | $121.09 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.20 | 2022-2025 | Spevigo |
| Genentech USA, INC. | $63.89 | 2022-2023 | Xolair |
| Epi Health, LLC | $47.76 | 2022 | |
| Smith+Nephew, INC. | $36.88 | 2019 | |
| Convatec INC. | $27.90 | 2025 | |
| Organon LLC | $18.91 | 2025 | Vtama |
| Biowound Solutions, INC. | $17.46 | 2025 | Bio-Connekt |
| Dermira, INC. | $16.60 | 2019 | |
| Strata Skin Sciences, INC. | $15.40 | 2024 | Xtrac |
| Integra Lifesciences Corporation | $14.67 | 2019 | |
| Allergan, INC. | $13.05 | 2022 | |
| Bioventus LLC | $12.24 | 2022 | |
| Mylan Pharmaceuticals INC. | $12.00 | 2019 | |
| Prugen, INC. Pharmaceuticals | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Centilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.